ETFs positioned on ResMed, Inc.

Name YTD change Weight AuM
+10.83% - 44,934 M€
+2.95% - 165 M€
+4.15% - 3 M€
+11.38% - 28 M€
+11.78% - 66 M€
+9.73% - 67 M€
+3.70% - 80 M€
+16.80% - 35,761 M€
+11.87% - 122 M€
+2.00% - 293 M€
+16.69% - 669 M€
+16.00% - 2,303 M€
+25.96%8.02% 4 M€
-12.16%4.61% 3,478 M€
+5.07%4.61% 31 M€
+21.96%4.23% 6 M€
+22.42%3.99% 0 M€
-13.18%2.83% 234 M€
-0.92%1.89% 2 M€
+5.98%1.87% 1,356 M€
+10.92%1.8% 9 M€
+3.32%1.77% 176 M€
+8.82%1.69% 8 M€
+24.62%1.64% 792 M€
+12.26%1.52% 31 M€
+12.18%1.25% 335 M€
+18.20%1.2% 131 M€
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370